| Income Statement | 2025-09-30 | 2024-09-30 | ||
|---|---|---|---|---|
| Total revenue | 0.983 | 10 | ||
| Research and development | 7.774 | 5.2 | ||
| General and administrative | 4.094 | 3.568 | ||
| Total operating expenses | 11.868 | 8.768 | ||
| Loss from operations | -10.885 | 1.232 | ||
| Interest income | 0.911 | 0.431 | ||
| Loss on issuance of common stock, pre-funded warrants and warrants in the 2024 pipe | 0 | - | ||
| Loss on amendment and cancellation of warrants | 0 | - | ||
| Loss on execution of the 2025 pipe | 0 | - | ||
| Loss (gain) on change in fair value of tranche liability | -40.748 | - | ||
| Gain on settlement of tranche liability | 0 | - | ||
| Other (expense) income, net (note 3) | -20.921 | -3.097 | ||
| Net income (loss) | -71.643 | -1.434 | ||
| Comprehensive income (loss), net of tax, attributable to parent | - | -1.434 | ||
| Earnings per share, basic | -8.36 | -0.44 | ||
| Earnings per share, diluted | -8.36 | -0.44 | ||
| Weighted average number of shares outstanding, basic | 8,571 | 3,228,000 | ||
| Weighted average number of shares outstanding, diluted | 8,571 | 3,228,000 | ||
Surrozen, Inc. DE (SRZN)
Surrozen, Inc. DE (SRZN)